{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:47:35Z","timestamp":1791863255587,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-4698"],"award-info":[{"award-number":["IIRP-2023-4698"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["File No. IIRP-2023-4698"],"award-info":[{"award-number":["File No. IIRP-2023-4698"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nano.2026.103022","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:46:51Z","timestamp":1789688811000},"page":"103022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ratiometric combinatorial delivery of docetaxel and erlotinib via folate-functionalized nanostructured lipid carriers for enhanced TNBC treatment"],"prefix":"10.1016","volume":"77","author":[{"given":"Aiswarya","family":"Chaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulla Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.nano.2026.103022_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2016.12.060","article-title":"Graphene quantum dots for cancer targeted drug delivery","volume":"518","author":"Iannazzo","year":"2017","journal-title":"Int J Pharm"},{"issue":"18","key":"10.1016\/j.nano.2026.103022_bb0010","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1039\/C7TB00287D","article-title":"Phycocyanin-based nanocarrier as a new nanoplatform for efficient overcoming of cancer drug resistance","volume":"5","author":"Huang","year":"2017","journal-title":"J Mater Chem B"},{"issue":"1","key":"10.1016\/j.nano.2026.103022_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.nano.2026.103022_bb0020","first-page":"393","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) \u2014 structural investigations on two different carrier systems","volume":"15","author":"Saupe","year":"2005","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.nano.2026.103022_bb0025","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1007\/s12668-024-01416-x","article-title":"Nanostructured lipid carrier: beneficial role in oral drug delivery system","volume":"14","author":"Soni","year":"2024","journal-title":"BioNanoScience"},{"key":"10.1016\/j.nano.2026.103022_bb0030","article-title":"Dual drug loaded nanostructured lipid carrier for cytotoxic effect against breast cancer - a drug repurposing approach","volume":"40","author":"Kumari","year":"2023","journal-title":"Surf Interfaces"},{"issue":"5","key":"10.1016\/j.nano.2026.103022_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25053066","article-title":"Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 Cells and MDA-MB-231 triple-negative breast cancer cells in vitro","volume":"25","author":"Abrahams","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.103022_bb0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41523-020-0147-1","article-title":"Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients","volume":"6","author":"Norton","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.nano.2026.103022_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6253978","article-title":"Anti-CD44 and EGFR dual-targeted solid lipid nanoparticles for delivery of doxorubicin to triple-negative breast cancer cell line: preparation, statistical optimization, and in vitro characterization","volume":"2022","author":"Darabi","year":"2022","journal-title":"Biomed Res Int"},{"issue":"7","key":"10.1016\/j.nano.2026.103022_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070926","article-title":"Combinatorial delivery of docetaxel- and erlotinib-loaded functionalized nanostructured lipid carriers for the treatment of triple-negative breast cancer using quality-by-design approach","volume":"16","author":"Chaudhuri","year":"2024","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.nano.2026.103022_bb0055","first-page":"5185","article-title":"Folate-targeted nanostructured lipid carriers (NLCs) enhance (letrozol) efficacy in MCF-7 breast cancer cells","volume":"17","author":"Sabzichi","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"25","key":"10.1016\/j.nano.2026.103022_bb0060","doi-asserted-by":"crossref","DOI":"10.1039\/c2jm31794j","article-title":"Synthesis, characterization, cellular uptake and cytotoxicity of a multi-functional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells","volume":"22","author":"Anirudhan","year":"2012","journal-title":"J Mater Chem"},{"issue":"11","key":"10.1016\/j.nano.2026.103022_bb0065","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/cam4.881","article-title":"Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways","volume":"5","author":"Shan","year":"2016","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.nano.2026.103022_bb0070","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-018-4382-4","article-title":"Effect of curcumin-loaded nanoparticles on mitochondrial dysfunctions of breast cancer cells","volume":"20","author":"Wang","year":"2018","journal-title":"J Nanopart Res"},{"issue":"1","key":"10.1016\/j.nano.2026.103022_bb0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2017.03.040","article-title":"Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel\/quercetin-loaded nanoparticles via Akt\/MMP-9 pathway","volume":"523","author":"Li","year":"2017","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.nano.2026.103022_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041167","article-title":"Functionalized hybrid iron oxide-gold nanoparticles targeting membrane Hsp70 radiosensitize triple-negative breast cancer cells by ROS-mediated apoptosis","volume":"15","author":"Wu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.nano.2026.103022_bb0085","first-page":"1","article-title":"Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer","volume":"12","author":"Kumar","year":"2022"},{"key":"10.1016\/j.nano.2026.103022_bb0090","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.actbio.2018.03.057","article-title":"Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management","volume":"73","author":"Kushwah","year":"2018","journal-title":"Acta Biomater"},{"issue":"5","key":"10.1016\/j.nano.2026.103022_bb0095","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"issue":"114","key":"10.1016\/j.nano.2026.103022_bb0100","first-page":"1","article-title":"Effects of quercetin-loaded nanoparticles on MCF-7 human breast cancer cells","volume":"55","author":"Niazvand","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.nano.2026.103022_bb0105","article-title":"Optimized scratch assay for in vitro testing of cell migration with an automated optical camera","volume":"138","author":"Vang Mouritzen","year":"2018","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.nano.2026.103022_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-81701-x","article-title":"PGMD\/curcumin nanoparticles for the treatment of breast cancer","volume":"11","author":"Kumari","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.103022_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00107","article-title":"In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.nano.2026.103022_bb0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejpb.2012.04.001","article-title":"Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study","volume":"81","author":"Zabaleta","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"10.1016\/j.nano.2026.103022_bb0125","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1021\/acs.molpharmaceut.6b00691","article-title":"Improving efficacy, oral bioavailability, and delivery of paclitaxel using protein-grafted solid lipid nanoparticles","volume":"13","author":"Pooja","year":"2016","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.nano.2026.103022_bb0130","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/bjc.2014.222","article-title":"Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation","volume":"110","author":"Hendrikx","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nano.2026.103022_bb0135","first-page":"6158","article-title":"Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir","volume":"62","author":"Bardelmeijer","year":"2002","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.nano.2026.103022_bb0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/aps.2011.209","article-title":"Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model","volume":"33","author":"Lai","year":"2012","journal-title":"Acta Pharmacol Sin"},{"issue":"1614","key":"10.1016\/j.nano.2026.103022_bb0145","first-page":"1","article-title":"In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells","volume":"9","author":"Nordin","year":"2019","journal-title":"Sci Rep"},{"issue":"105657","key":"10.1016\/j.nano.2026.103022_bb0150","first-page":"1","article-title":"In vivo synergistic anti-tumor effect of lumefantrine combined with pH responsive behavior of nano calcium phosphate based lipid nanoparticles on lung cancer","volume":"158","author":"Sethuraman","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2026.103022_bb0155","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2147\/IJN.S400329","article-title":"Luteolin-loaded nanoparticles for the treatment of melanoma","volume":"18","author":"Fu","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"10.1016\/j.nano.2026.103022_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph15050542","article-title":"Emergence of nanotechnology as a powerful cavalry against triple-negative breast cancer (TNBC)","volume":"15","author":"Chaudhuri","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nano.2026.103022_bb0165","first-page":"21","article-title":"Pharmacokinetics and toxicities of oral docetaxel formulations co-administered with ritonavir in phase I trials","volume":"13","author":"Vermunt","year":"2021","journal-title":"Clin Pharm"},{"key":"10.1016\/j.nano.2026.103022_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cej.2022.135305","article-title":"pH-responsive nanomedicine co-encapsulated with Erlotinib and chlorin e6 can enable effective treatment of triple negative breast cancer via reprogramming tumor vasculature","volume":"437","author":"Liu","year":"2022","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nano.2026.103022_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2020.109230","article-title":"Design and fabrication of cell-targeted, dual drug-loaded nanoparticles with pH-controlled drug release and near-infrared light-induced photothermal effects","volume":"197","author":"Weng","year":"2021","journal-title":"Mater Des"},{"key":"10.1016\/j.nano.2026.103022_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.colsurfb.2016.05.051","article-title":"Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics","volume":"146","author":"Garg","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"11","key":"10.1016\/j.nano.2026.103022_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis"},{"issue":"7","key":"10.1016\/j.nano.2026.103022_bb0190","first-page":"1","article-title":"Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44","volume":"15","author":"Wang","year":"2017","journal-title":"J Nanobiotechnol"},{"issue":"8","key":"10.1016\/j.nano.2026.103022_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.nano.2026.103022_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nano11113154","article-title":"Anticancer potential of L-Histidine-capped silver nanoparticles against human cervical cancer cells (SiHA)","volume":"11","author":"Mohammed Asik","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.nano.2026.103022_bb0205","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/IJN.S249240","article-title":"ROS-responsive chitosan coated magnetic iron oxide nanoparticles as potential vehicles for targeted drug delivery in cancer therapy","volume":"15","author":"Ayyanaar","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"10.1016\/j.nano.2026.103022_bb0210","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/ijc.32270","article-title":"Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression","volume":"145","author":"Arroyo-Crespo","year":"2019","journal-title":"Int J Cancer"},{"issue":"394","key":"10.1016\/j.nano.2026.103022_bb0215","first-page":"1","article-title":"Current methods for studying metastatic potential of tumor cells","volume":"22","author":"Bouchalova","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.nano.2026.103022_bb0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2017.07.013","article-title":"Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats","volume":"143","author":"Qin","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.nano.2026.103022_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10040199","article-title":"Sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: characterization, cellular uptake, cytotoxicity, and biodistribution","volume":"10","author":"Kim","year":"2018","journal-title":"Pharmaceutics"},{"issue":"43","key":"10.1016\/j.nano.2026.103022_bb0230","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.1313839110","article-title":"Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption","volume":"110","author":"Attili-Qadri","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.nano.2026.103022_bb0235","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.nano.2018.04.009","article-title":"Co-delivery of docetaxel and gemcitabine using PEGylated self-assembled stealth nanoparticles for improved breast cancer therapy","volume":"14","author":"Kushwah","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2026.103022_bb0240","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.2147\/OTT.S259428","article-title":"Doxorubicin and edelfosine combo-loaded lipid-polymer hybrid nanoparticles for synergistic anticancer effect against drug-resistant osteosarcoma","volume":"13","author":"Yang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.nano.2026.103022_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.146330","article-title":"Development and statistical optimization of camptothecin loaded hyaluronic acid and zein polymeric nanoparticles towards the treatment of melanoma","volume":"321","author":"Batool","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/j.nano.2026.103022_bb0250","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40005-025-00753-7","article-title":"Palbociclib- and regorafenib-loaded nanomicelles for the treatment of non-small cell lung cancer: pharmacokinetic and antitumor evaluations","volume":"56","author":"Malik","year":"2025","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.nano.2026.103022_bb0255","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jconrel.2024.08.034","article-title":"Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery","volume":"374","author":"Din","year":"2024","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.nano.2026.103022_bb0260","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s12274-017-1444-3","article-title":"Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma","volume":"10","author":"Depalo","year":"2017","journal-title":"Nano Res"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426001231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:25:42Z","timestamp":1791861942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S1549963426001231"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.103022","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ratiometric combinatorial delivery of docetaxel and erlotinib via folate-functionalized nanostructured lipid carriers for enhanced TNBC treatment","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.103022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103022"}}